Design, Synthesis, and Protective Effect Evaluation on Myocardial Ischemia of New Triazole Aldehyde Dehydrogenase 2
Fengping Zhao1, Xin Pan2, Xi Chen1
1The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University (Second Military Medical University), Shanghai 200433, China.
Abstract:
Myocardial infarction (MI) is a serious human health problem, with high mortality and unfavorable prognosis. In this study, new triazole aldehyde dehydrogenase 2 (ALDH2) activators with improved water solubility and activity were discovered with the aid of molecular simulation. The ALDH2 maximum activation fold of representative compound Z17 reached 5.4, which is 304% calibrated against the positive control Alda-1. This activation activity represents the highest activity among the compounds which have been reported so far to our knowledge. This compound exhibited significant efficacy not only in enhancing cardiac function (improved cardiac ejection fraction by 41% and fractional shortening by 36%) but also in mitigating myocardial necrosis (improved the size of myocardial infarction by 38%, levels of LDH by 35% and CK-MB by 69%) in a mice model of myocardial ischemia-reperfusion via intraperitoneal injection. This study provides a good basis for further research on ALDH2 activators to treat MI.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...


